From neurological impairment to metabolic issues, mitochondrial diseases encompass a range of symptoms. As a complex condition, they require new therapeutic strategies that target their specific molecular features. Understanding the need of the hour, Protheragen stands ready with specialized therapeutic development services for mitochondrial diseases. Using our extensive knowledge in drug development and mitochondrial biology, we provide a comprehensive suite of solutions to aid in the therapy development of these diseases.
Our Services
As a research service provider with a specialization in mitochondrial diseases, we are proud to be one of the leading companies in the industry since we offer a comprehensive suite of services that support the development of therapeutics based on various aspects of mitochondrial dysfunctions. From target selection and disease modeling to drug development and preclinical studies, we are focused on fostering the development and advancement of therapies for mitochondrial diseases.
Mitochondrial Disease Target Development & Identification Service
The purpose of focusing on the detection and development of novel therapeutic targets is to pinpoint novel targets linked to mitochondrial dysfunction using bioinformatics, high-throughput screening, and functional validation approaches. We assist researchers in delineating drug development targets, which helps to create next-generation therapies for mitochondrial diseases.
Mitochondrial Disease Model Development Service
The mitochondrial disease model development service assists researchers in developing cell and animal models for mitochondrial diseases. Our services range from accurately replicating the cellular pathology and phenotype of disease to permitting the research of a disease’s mechanisms, screening possible therapeutics, and testing therapy effectiveness in preclinical studies.
Drug Development Service for Mitochondrial Diseases
To facilitate promising therapeutic candidates from discovery to business translation, we provide a drug development service for mitochondrial diseases. This includes drug screening, delivery systems development, preclinical research, and even regulation support, which help ease the drug development process and, in turn, the transition from bench to bedside.
In Vitro Mitochondrial Analysis Service
In vitro, mitochondrial analysis service focus on providing researchers with an extensive range of assays and diagnostic methods used to analyze the functional, structural, and integral aspects of a mitochondrion. We assist in the ascertainment and confirmation of therapeutic targets and evaluation of drug candidates for mitochondrial diseases by giving researchers an elaborate analysis of the bioenergetics, morphology, damage, and protein composition of the mitochondrion.
In Vivo Mitochondrial Fission and Fusion Analysis
Services for mitochondrial fission and fusion analysis in vivo maintain a focus on providing services centered around the study of processes of mitochondrial dynamics in living organisms. Detecting fission and fusion events in vivo makes it possible for researchers to understand the role of mitochondrial dynamics in health and disease and develop relevant intervention methods for various mitochondrial diseases.
Our Advantages
Protheragen's therapeutic development services pertaining to mitochondrial diseases enable us to offer an integrated platform that expedites the identification and development of effective therapies for mitochondrial disease. Contact us to make an impactful contribution to the fight against mitochondrial diseases.
